Dabomb Protein
DaBomb Protein Biotech Corp. manufactures and sells hydrolyzed soy protein in Vietnam, the Philippines, South Korea, Taiwan, and Asia. It offers plant protein, including DaBomb-P (Aqua) and DaBomb-P (Livestock); antibiotics alternatives, such as DBT-100 HT and DBT-100 LS; and pet care products comprising Liqui-TIDE bandages. The company was formerly known as DaBomb Protein Corp. and changed its n… Read more
Dabomb Protein (6578) - Total Assets
Latest total assets as of June 2025: NT$1.23 Billion TWD
Based on the latest financial reports, Dabomb Protein (6578) holds total assets worth NT$1.23 Billion TWD as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Dabomb Protein - Total Assets Trend (2015–2024)
This chart illustrates how Dabomb Protein’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Dabomb Protein - Asset Composition Analysis
Current Asset Composition (December 2024)
Dabomb Protein's total assets of NT$1.23 Billion consist of 49.7% current assets and 50.3% non-current assets.
| Asset Category | Amount (TWD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 19.3% |
| Accounts Receivable | NT$32.28 Million | 2.5% |
| Inventory | NT$34.07 Million | 2.6% |
| Property, Plant & Equipment | NT$0.00 | 0.0% |
| Intangible Assets | NT$0.00 | 0.0% |
| Goodwill | NT$0.00 | 0.0% |
Asset Composition Trend (2015–2024)
This chart illustrates how Dabomb Protein's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Dabomb Protein's current assets represent 49.7% of total assets in 2024, a decrease from 77.3% in 2015.
- Cash Position: Cash and equivalents constituted 19.3% of total assets in 2024, down from 63.2% in 2015.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2015.
- Asset Diversification: The largest asset category is inventory at 2.6% of total assets.
Dabomb Protein Competitors by Total Assets
Key competitors of Dabomb Protein based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
General Mills Inc
NYSE:GIS
|
USA | $32.55 Billion |
|
Maniker F & G Co. Ltd
KQ:195500
|
Korea | ₩123.42 Billion |
|
Xiwang Foodstuffs Co Ltd
SHE:000639
|
China | CN¥6.08 Billion |
|
Nanfang Black Sesame Group Co Ltd
SHE:000716
|
China | CN¥4.57 Billion |
|
CNFC Overseas Fishery Co Ltd
SHE:000798
|
China | CN¥5.88 Billion |
|
Henan Shuanghui Investment & Development Co Ltd
SHE:000895
|
China | CN¥40.64 Billion |
|
Xinjiang Chalkis Co Ltd
SHE:000972
|
China | CN¥1.25 Billion |
|
Daehan Flour Mills Co Ltd
KO:001130
|
Korea | ₩1.61 Trillion |
Dabomb Protein - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Dabomb Protein generates 0.26x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Dabomb Protein generates $ 0.88 in net profit.
Dabomb Protein - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.31 | 2.50 | 1.79 |
| Quick Ratio | 3.18 | 2.39 | 1.62 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | NT$388.01 Million | NT$ 457.29 Million | NT$ 186.55 Million |
Dabomb Protein - Advanced Valuation Insights
This section examines the relationship between Dabomb Protein's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.27 |
| Latest Market Cap to Assets Ratio | 0.02 |
| Asset Growth Rate (YoY) | -6.2% |
| Total Assets | NT$1.32 Billion |
| Market Capitalization | $19.73 Million USD |
Valuation Analysis
Below Book Valuation: The market values Dabomb Protein's assets below their book value (0.02 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Dabomb Protein's assets decreased by 6.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Dabomb Protein (2015–2024)
The table below shows the annual total assets of Dabomb Protein from 2015 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | NT$1.32 Billion | -6.18% |
| 2023-12-31 | NT$1.40 Billion | +9.52% |
| 2022-12-31 | NT$1.28 Billion | -4.22% |
| 2021-12-31 | NT$1.34 Billion | +26.42% |
| 2020-12-31 | NT$1.06 Billion | +14.99% |
| 2019-12-31 | NT$919.35 Million | +9.20% |
| 2018-12-31 | NT$841.91 Million | -1.07% |
| 2017-12-31 | NT$851.06 Million | +3.80% |
| 2016-12-31 | NT$819.88 Million | +12.32% |
| 2015-12-31 | NT$729.95 Million | -- |